GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vext Science Inc (XCNQ:VEXT) » Definitions » Equity-to-Asset

Vext Science (XCNQ:VEXT) Equity-to-Asset : 0.61 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Vext Science Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Vext Science's Total Stockholders Equity for the quarter that ended in Mar. 2024 was C$120.01 Mil. Vext Science's Total Assets for the quarter that ended in Mar. 2024 was C$196.56 Mil. Therefore, Vext Science's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.61.

The historical rank and industry rank for Vext Science's Equity-to-Asset or its related term are showing as below:

XCNQ:VEXT' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.56   Med: 0.66   Max: 0.77
Current: 0.61

During the past 7 years, the highest Equity to Asset Ratio of Vext Science was 0.77. The lowest was 0.56. And the median was 0.66.

XCNQ:VEXT's Equity-to-Asset is ranked better than
55.65% of 1089 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs XCNQ:VEXT: 0.61

Vext Science Equity-to-Asset Historical Data

The historical data trend for Vext Science's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vext Science Equity-to-Asset Chart

Vext Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.66 0.66 0.71 0.60 0.64

Vext Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.60 0.60 0.64 0.61

Competitive Comparison of Vext Science's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Vext Science's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vext Science's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vext Science's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Vext Science's Equity-to-Asset falls into.



Vext Science Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Vext Science's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=127.428/200.65
=0.64

Vext Science's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=120.013/196.562
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vext Science  (XCNQ:VEXT) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Vext Science Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Vext Science's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Vext Science (XCNQ:VEXT) Business Description

Traded in Other Exchanges
Address
4152 N. 39th Avenue, Phoenix, AZ, USA, 85019
Vext Science Inc provides management, advisory, cultivation, and dispensary services to entities in the medical cannabis field. The company's expertise spans from cultivation through to retail operations. Its revenue sources include management fees, professional services, product sales, equipment leasing and property leasing.
Executives
Caroline Marie-clothilde Williams Director

Vext Science (XCNQ:VEXT) Headlines

No Headlines